To examine the effect of this compound on breast cancer progression, we established an orthotopic, syngeneic mouse model of 4T1 breast cancer which is well known for its strong intratumoral expression of uPA and PAI‐1 (Fig 4C). Here, PLAU is linked to breast carcinoma.